Cx Institutional Novo Nordisk A S Transaction History

Cx Institutional

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $51,620 - $60,905	500 New	500 $56,000
Q4 2021 Jan 18, 2022	SELL	$95.88 - $117.08 $47,940 - $58,540	-500 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $58,540 - $67,940	-1,000 Reduced 66.67%	500 $33,000
Q1 2020 Apr 29, 2020	BUY	$49.46 - $64.78 $74,190 - $97,170	1,500 New	1,500 $90,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.